Human Vaccine Market Report

Europe Human Vaccine Market Size, Status and Forecast 2014-2026

  • POSTDATE：Feb 27, 2020
  • PAGES：156
  • REPORT CODE：GMM486806
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The Human Vaccine market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 5.7% during the forecast period. Focusing on the Europe market, this report analyzes the specific consumption structure, such as types and end users. In order to present the status of the circulation of this product in different Europe countries, this report covers top export and import countries to confirm the potential markets. Leading countries such as Germany, UK, France, Italy, Spain, Poland, Russia, Switzerland, Turkey, Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden), Benelux (Belgium, Netherlands, and Luxembourg), Baltic States (Estonia, Latvia, and Lithuania) and other countries, the market status and consumption potential of these countries are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Europe Human Vaccine Market Segmentations:

    By Player:

    • SINOVAC BIOTECH

    • Hualan Bio

    • Tiantan biological

    • CNBG

    • Zhongyianke Biotech

    • Adimmune

    • Walvax Biotechnology

    • Rong An

    • SANOFI

    • GSK

    • Zhifei

    • Kangtai

    • ChengDa Bio

    • Hissen

    • Changchun Baike

    • NuoCheng Bio

    • Changsheng Life

    By Type:

    • Varicella

    • Influenza

    • Polio

    • Hepatitis A

    • Rabies

    • BCG

    • Hepatitis B

    • Pertussis, Diphtheria, Tetanus

    • Pneumococcal

    • Rota vaccine

    By End-User:

    • Adults

    • Children

    By Region:

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Poland

    • Russia

    • Switzerland

    • Turkey

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

      • Denmark

      • Finland

      • Norway

      • Sweden

      • Iceland

    • Benelux (Belgium, Netherlands, and Luxembourg)

      • Belgium

      • Netherlands

      • Luxembourg

    • Baltic States (Estonia, Latvia, and Lithuania)

      • Estonia

      • Latvia

      • Lithuania

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Human Vaccine Market

    • 1.3 Market Segment by Type

    • 1.3.1 Europe Human Vaccine Market Size and Growth Rate of Varicella from 2014 to 2026

    • 1.3.2 Europe Human Vaccine Market Size and Growth Rate of Influenza from 2014 to 2026

    • 1.3.3 Europe Human Vaccine Market Size and Growth Rate of Polio from 2014 to 2026

    • 1.3.4 Europe Human Vaccine Market Size and Growth Rate of Hepatitis A from 2014 to 2026

    • 1.3.5 Europe Human Vaccine Market Size and Growth Rate of Rabies from 2014 to 2026

    • 1.3.6 Europe Human Vaccine Market Size and Growth Rate of BCG from 2014 to 2026

    • 1.3.7 Europe Human Vaccine Market Size and Growth Rate of Hepatitis B from 2014 to 2026

    • 1.3.8 Europe Human Vaccine Market Size and Growth Rate of Pertussis, Diphtheria, Tetanus from 2014 to 2026

    • 1.3.9 Europe Human Vaccine Market Size and Growth Rate of Pneumococcal from 2014 to 2026

    • 1.3.10 Europe Human Vaccine Market Size and Growth Rate of Rota vaccine from 2014 to 2026

    • 1.4 Market Segment by Application

    • 1.4.1 Europe Human Vaccine Market Size and Growth Rate of Adults from 2014 to 2026

    • 1.4.2 Europe Human Vaccine Market Size and Growth Rate of Children from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Germany Human Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 UK Human Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 France Human Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Italy Human Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Spain Human Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Poland Human Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Russia Human Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Switzerland Human Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.9 Turkey Human Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Human Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.11 Benelux (Belgium, Netherlands, and Luxembourg) Human Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.12 Baltic States (Estonia, Latvia, and Lithuania) Human Vaccine Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Human Vaccine Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Venders

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Human Vaccine by Major Types

      • 3.4.1 Market Size and Growth Rate of Varicella

      • 3.4.2 Market Size and Growth Rate of Influenza

      • 3.4.3 Market Size and Growth Rate of Polio

      • 3.4.4 Market Size and Growth Rate of Hepatitis A

      • 3.4.5 Market Size and Growth Rate of Rabies

      • 3.4.6 Market Size and Growth Rate of BCG

      • 3.4.7 Market Size and Growth Rate of Hepatitis B

      • 3.4.8 Market Size and Growth Rate of Pertussis, Diphtheria, Tetanus

      • 3.4.9 Market Size and Growth Rate of Pneumococcal

      • 3.4.10 Market Size and Growth Rate of Rota vaccine

    4 Segmentation of Human Vaccine Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Human Vaccine by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Human Vaccine for Adults

      • 4.4.2 Market Size and Growth Rate of Human Vaccine for Children

    5 Market Analysis by Major Regions

    • 5.1 Europe Human Vaccine Production Analysis by Top Regions

    • 5.2 Europe Human Vaccine Consumption Analysis by Top Regions

    • 5.3 Europe Human Vaccine Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 Germany Human Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.2 UK Human Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.3 France Human Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.4 Italy Human Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.5 Spain Human Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.6 Poland Human Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.7 Russia Human Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.8 Switzerland Human Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.9 Turkey Human Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Human Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.11 Benelux (Belgium, Netherlands, and Luxembourg) Human Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.12 Baltic States (Estonia, Latvia, and Lithuania) Human Vaccine Production, Import, Consumption and Export Analysis

    6 Product Circulation of Human Vaccine Market among Top Countries

    • 6.1 Top 5 Export Countries in Human Vaccine Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in Human Vaccine Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in Human Vaccine Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Human Vaccine Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in Human Vaccine Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in Human Vaccine Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. Germany Human Vaccine Landscape Analysis

    • 7.1 Germany Human Vaccine Landscape Analysis by Major Types

    • 7.2 Germany Human Vaccine Landscape Analysis by Major End-Users

    8. UK Human Vaccine Landscape Analysis

    • 8.1 UK Human Vaccine Landscape Analysis by Major Types

    • 8.2 UK Human Vaccine Landscape Analysis by Major End-Users

    9. France Human Vaccine Landscape Analysis

    • 9.1 France Human Vaccine Landscape Analysis by Major Types

    • 9.2 France Human Vaccine Landscape Analysis by Major End-Users

    10. Italy Human Vaccine Landscape Analysis

    • 10.1 Italy Human Vaccine Landscape Analysis by Major Types

    • 10.2 Italy Human Vaccine Landscape Analysis by Major End-Users

    11. Spain Human Vaccine Landscape Analysis

    • 11.1 Spain Human Vaccine Landscape Analysis by Major Types

    • 11.2 Spain Human Vaccine Landscape Analysis by Major End-Users

    12. Poland Human Vaccine Landscape Analysis

    • 12.1 Poland Human Vaccine Landscape Analysis by Major Types

    • 12.2 Poland Human Vaccine Landscape Analysis by Major End-Users

    13. Russia Human Vaccine Landscape Analysis

    • 13.1 Russia Human Vaccine Landscape Analysis by Major Types

    • 13.2 Russia Human Vaccine Landscape Analysis by Major End-Users

    14. Switzerland Human Vaccine Landscape Analysis

    • 14.1 Switzerland Human Vaccine Landscape Analysis by Major Types

    • 14.2 Switzerland Human Vaccine Landscape Analysis by Major End-Users

    15. Turkey Human Vaccine Landscape Analysis

    • 15.1 Turkey Human Vaccine Landscape Analysis by Major Types

    • 15.2 Turkey Human Vaccine Landscape Analysis by Major End-Users

    16. Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Human Vaccine Landscape Analysis

    • 16.1 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Human Vaccine Landscape Analysis by Major Types

    • 16.2 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Human Vaccine Landscape Analysis by Major End-Users

    • 16.3 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Human Vaccine Landscape Analysis by Top Countries

      • 16.3.1 Denmark Human Vaccine Market Volume and Growth Rate

      • 16.3.2 Finland Human Vaccine Market Volume and Growth Rate

      • 16.3.3 Norway Human Vaccine Market Volume and Growth Rate

      • 16.3.4 Sweden Human Vaccine Market Volume and Growth Rate

      • 16.3.6 Iceland Human Vaccine Market Volume and Growth Rate

    17 Benelux (Belgium, Netherlands, and Luxembourg) Human Vaccine Landscape Analysis

    • 17.1 Benelux (Belgium, Netherlands, and Luxembourg) Human Vaccine Landscape Analysis by Major Types

    • 17.2 Benelux (Belgium, Netherlands, and Luxembourg) Human Vaccine Landscape Analysis by Major End-Users

    • 17.3 Benelux (Belgium, Netherlands, and Luxembourg) Human Vaccine Landscape Analysis by Top Countries

      • 17.3.1 Belgium Human Vaccine Market Volume and Growth Rate

      • 17.3.2 Netherlands Human Vaccine Market Volume and Growth Rate

      • 17.3.3 Luxembourg Human Vaccine Market Volume and Growth Rate

    18 Baltic States (Estonia, Latvia, and Lithuania) Human Vaccine Landscape Analysis

    • 18.1 Baltic States (Estonia, Latvia, and Lithuania) Human Vaccine Landscape Analysis by Major Types

    • 18.2 Baltic States (Estonia, Latvia, and Lithuania) Human Vaccine Landscape Analysis by Major End-Users

    • 18.3 Baltic States (Estonia, Latvia, and Lithuania) Human Vaccine Landscape Analysis by Top Countries

      • 18.3.1 Estonia Human Vaccine Market Volume and Growth Rate

      • 18.3.2 Latvia Human Vaccine Market Volume and Growth Rate

      • 18.3.3 Lithuania Human Vaccine Market Volume and Growth Rate

    19 Major Players Profiles

    • 19.1 SINOVAC BIOTECH

      • 19.1.1 SINOVAC BIOTECH Company Profile and Development Status

      • 19.1.2 Market Performance

      • 19.1.3 Product and Service Introduction

    • 19.2 Hualan Bio

      • 19.2.1 Hualan Bio Company Profile and Development Status

      • 19.2.2 Market Performance

      • 19.2.3 Product and Service Introduction

    • 19.3 Tiantan biological

      • 19.3.1 Tiantan biological Company Profile and Development Status

      • 19.3.2 Market Performance

      • 19.3.3 Product and Service Introduction

    • 19.4 CNBG

      • 19.4.1 CNBG Company Profile and Development Status

      • 19.4.2 Market Performance

      • 19.4.3 Product and Service Introduction

    • 19.5 Zhongyianke Biotech

      • 19.5.1 Zhongyianke Biotech Company Profile and Development Status

      • 19.5.2 Market Performance

      • 19.5.3 Product and Service Introduction

    • 19.6 Adimmune

      • 19.6.1 Adimmune Company Profile and Development Status

      • 19.6.2 Market Performance

      • 19.6.3 Product and Service Introduction

    • 19.7 Walvax Biotechnology

      • 19.7.1 Walvax Biotechnology Company Profile and Development Status

      • 19.7.2 Market Performance

      • 19.7.3 Product and Service Introduction

    • 19.8 Rong An

      • 19.8.1 Rong An Company Profile and Development Status

      • 19.8.2 Market Performance

      • 19.8.3 Product and Service Introduction

    • 19.9 SANOFI

      • 19.9.1 SANOFI Company Profile and Development Status

      • 19.9.2 Market Performance

      • 19.9.3 Product and Service Introduction

    • 19.10 GSK

      • 19.10.1 GSK Company Profile and Development Status

      • 19.10.2 Market Performance

      • 19.10.3 Product and Service Introduction

    • 19.11 Zhifei

      • 19.11.1 Zhifei Company Profile and Development Status

      • 19.11.2 Market Performance

      • 19.11.3 Product and Service Introduction

    • 19.12 Kangtai

      • 19.12.1 Kangtai Company Profile and Development Status

      • 19.12.2 Market Performance

      • 19.12.3 Product and Service Introduction

    • 19.13 ChengDa Bio

      • 19.13.1 ChengDa Bio Company Profile and Development Status

      • 19.13.2 Market Performance

      • 19.13.3 Product and Service Introduction

    • 19.14 Hissen

      • 19.14.1 Hissen Company Profile and Development Status

      • 19.14.2 Market Performance

      • 19.14.3 Product and Service Introduction

    • 19.15 Changchun Baike

      • 19.15.1 Changchun Baike Company Profile and Development Status

      • 19.15.2 Market Performance

      • 19.15.3 Product and Service Introduction

    • 19.16 NuoCheng Bio

      • 19.16.1 NuoCheng Bio Company Profile and Development Status

      • 19.16.2 Market Performance

      • 19.16.3 Product and Service Introduction

    • 19.17 Changsheng Life

      • 19.17.1 Changsheng Life Company Profile and Development Status

      • 19.17.2 Market Performance

      • 19.17.3 Product and Service Introduction

    The List of Tables and Figures (Totals 85 Figures and 137 Tables)

    • Figure Product Picture

    • Figure Europe Human Vaccine Market Size and Growth Rate of Varicella from 2014 to 2026

    • Figure Europe Human Vaccine Market Size and Growth Rate of Influenza from 2014 to 2026

    • Figure Europe Human Vaccine Market Size and Growth Rate of Polio from 2014 to 2026

    • Figure Europe Human Vaccine Market Size and Growth Rate of Hepatitis A from 2014 to 2026

    • Figure Europe Human Vaccine Market Size and Growth Rate of Rabies from 2014 to 2026

    • Figure Europe Human Vaccine Market Size and Growth Rate of BCG from 2014 to 2026

    • Figure Europe Human Vaccine Market Size and Growth Rate of Hepatitis B from 2014 to 2026

    • Figure Europe Human Vaccine Market Size and Growth Rate of Pertussis, Diphtheria, Tetanus from 2014 to 2026

    • Figure Europe Human Vaccine Market Size and Growth Rate of Pneumococcal from 2014 to 2026

    • Figure Europe Human Vaccine Market Size and Growth Rate of Rota vaccine from 2014 to 2026

    • Figure Europe Human Vaccine Market Size and Growth Rate of Adults from 2014 to 2026

    • Figure Europe Human Vaccine Market Size and Growth Rate of Children from 2014 to 2026

    • Figure Germany Human Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure UK Human Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure France Human Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Human Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Human Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Human Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Human Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Switzerland Human Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Human Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Human Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Human Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Human Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Denmark Human Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Finland Human Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Norway Human Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Sweden Human Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Iceland Human Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Benelux (Belgium, Netherlands, and Luxembourg) Human Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Human Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Netherlands Human Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Luxembourg Human Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Baltic States (Estonia, Latvia, and Lithuania) Human Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Estonia Human Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Latvia Human Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Lithuania Human Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Human Vaccine Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Human Vaccine

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Human Vaccine by Different Types from 2014 to 2026

    • Table Consumption Share of Human Vaccine by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Varicella

    • Figure Market Size and Growth Rate of Influenza

    • Figure Market Size and Growth Rate of Polio

    • Figure Market Size and Growth Rate of Hepatitis A

    • Figure Market Size and Growth Rate of Rabies

    • Figure Market Size and Growth Rate of BCG

    • Figure Market Size and Growth Rate of Hepatitis B

    • Figure Market Size and Growth Rate of Pertussis, Diphtheria, Tetanus

    • Figure Market Size and Growth Rate of Pneumococcal

    • Figure Market Size and Growth Rate of Rota vaccine

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Human Vaccine by Different End-Users from 2014 to 2026

    • Table Consumption Share of Human Vaccine by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Adults

    • Figure Market Size and Growth Rate of Children

    • Table Europe Human Vaccine Production by Major Regions

    • Table Europe Human Vaccine Production Share by Major Regions

    • Figure Europe Human Vaccine Production Share by Major Countries and Regions in 2014

    • Table Europe Human Vaccine Consumption by Major Regions

    • Table Europe Human Vaccine Consumption Share by Major Regions

    • Table Germany Human Vaccine Production, Import, Consumption and Export Analysis

    • Table UK Human Vaccine Production, Import, Consumption and Export Analysis

    • Table France Human Vaccine Production, Import, Consumption and Export Analysis

    • Table Italy Human Vaccine Production, Import, Consumption and Export Analysis

    • Table Spain Human Vaccine Production, Import, Consumption and Export Analysis

    • Table Poland Human Vaccine Production, Import, Consumption and Export Analysis

    • Table Russia Human Vaccine Production, Import, Consumption and Export Analysis

    • Table Switzerland Human Vaccine Production, Import, Consumption and Export Analysis

    • Table Turkey Human Vaccine Production, Import, Consumption and Export Analysis

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Human Vaccine Production, Import, Consumption and Export Analysis

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Human Vaccine Production, Import, Consumption and Export Analysis

    • Table Baltic States (Estonia, Latvia, and Lithuania) Human Vaccine Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Human Vaccine Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Human Vaccine Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Human Vaccine Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Human Vaccine Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table Germany Human Vaccine Consumption by Types from 2014 to 2026

    • Table Germany Human Vaccine Consumption Share by Types from 2014 to 2026

    • Table Germany Human Vaccine Consumption by End-Users from 2014 to 2026

    • Table Germany Human Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table UK Human Vaccine Consumption by Types from 2014 to 2026

    • Table UK Human Vaccine Consumption Share by Types from 2014 to 2026

    • Table UK Human Vaccine Consumption by End-Users from 2014 to 2026

    • Table UK Human Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table France Human Vaccine Consumption by Types from 2014 to 2026

    • Table France Human Vaccine Consumption Share by Types from 2014 to 2026

    • Table France Human Vaccine Consumption by End-Users from 2014 to 2026

    • Table France Human Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table Italy Human Vaccine Consumption by Types from 2014 to 2026

    • Table Italy Human Vaccine Consumption Share by Types from 2014 to 2026

    • Table Italy Human Vaccine Consumption by End-Users from 2014 to 2026

    • Table Italy Human Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table Spain Human Vaccine Consumption by Types from 2014 to 2026

    • Table Spain Human Vaccine Consumption Share by Types from 2014 to 2026

    • Table Spain Human Vaccine Consumption by End-Users from 2014 to 2026

    • Table Spain Human Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table Poland Human Vaccine Consumption by Types from 2014 to 2026

    • Table Poland Human Vaccine Consumption Share by Types from 2014 to 2026

    • Table Poland Human Vaccine Consumption by End-Users from 2014 to 2026

    • Table Poland Human Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table Russia Human Vaccine Consumption by Types from 2014 to 2026

    • Table Russia Human Vaccine Consumption Share by Types from 2014 to 2026

    • Table Russia Human Vaccine Consumption by End-Users from 2014 to 2026

    • Table Russia Human Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table Switzerland Human Vaccine Consumption by Types from 2014 to 2026

    • Table Switzerland Human Vaccine Consumption Share by Types from 2014 to 2026

    • Table Switzerland Human Vaccine Consumption by End-Users from 2014 to 2026

    • Table Switzerland Human Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table Turkey Human Vaccine Consumption by Types from 2014 to 2026

    • Table Turkey Human Vaccine Consumption Share by Types from 2014 to 2026

    • Table Turkey Human Vaccine Consumption by End-Users from 2014 to 2026

    • Table Turkey Human Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Human Vaccine Consumption by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Human Vaccine Consumption Share by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Human Vaccine Consumption by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Human Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Human Vaccine Consumption by Major Countries from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Human Vaccine Consumption Share by Major Countries from 2014 to 2026

    • Figure Denmark Human Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland Human Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway Human Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden Human Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland Human Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Human Vaccine Consumption by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Human Vaccine Consumption Share by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Human Vaccine Consumption by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Human Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Human Vaccine Consumption by Major Countries from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Human Vaccine Consumption Share by Major Countries from 2014 to 2026

    • Figure Belgium Human Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands Human Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Luxembourg Human Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Human Vaccine Consumption by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Human Vaccine Consumption Share by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Human Vaccine Consumption by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Human Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Human Vaccine Consumption by Major Countries from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Human Vaccine Consumption Share by Major Countries from 2014 to 2026

    • Figure Estonia Human Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Latvia Human Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Lithuania Countries Human Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of SINOVAC BIOTECH

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of SINOVAC BIOTECH

    • Figure Sales and Growth Rate Analysis of SINOVAC BIOTECH

    • Figure Revenue and Market Share Analysis of SINOVAC BIOTECH

    • Table Product and Service Introduction of SINOVAC BIOTECH

    • Table Company Profile and Development Status of Hualan Bio

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Hualan Bio

    • Figure Sales and Growth Rate Analysis of Hualan Bio

    • Figure Revenue and Market Share Analysis of Hualan Bio

    • Table Product and Service Introduction of Hualan Bio

    • Table Company Profile and Development Status of Tiantan biological

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Tiantan biological

    • Figure Sales and Growth Rate Analysis of Tiantan biological

    • Figure Revenue and Market Share Analysis of Tiantan biological

    • Table Product and Service Introduction of Tiantan biological

    • Table Company Profile and Development Status of CNBG

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of CNBG

    • Figure Sales and Growth Rate Analysis of CNBG

    • Figure Revenue and Market Share Analysis of CNBG

    • Table Product and Service Introduction of CNBG

    • Table Company Profile and Development Status of Zhongyianke Biotech

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Zhongyianke Biotech

    • Figure Sales and Growth Rate Analysis of Zhongyianke Biotech

    • Figure Revenue and Market Share Analysis of Zhongyianke Biotech

    • Table Product and Service Introduction of Zhongyianke Biotech

    • Table Company Profile and Development Status of Adimmune

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Adimmune

    • Figure Sales and Growth Rate Analysis of Adimmune

    • Figure Revenue and Market Share Analysis of Adimmune

    • Table Product and Service Introduction of Adimmune

    • Table Company Profile and Development Status of Walvax Biotechnology

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Walvax Biotechnology

    • Figure Sales and Growth Rate Analysis of Walvax Biotechnology

    • Figure Revenue and Market Share Analysis of Walvax Biotechnology

    • Table Product and Service Introduction of Walvax Biotechnology

    • Table Company Profile and Development Status of Rong An

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Rong An

    • Figure Sales and Growth Rate Analysis of Rong An

    • Figure Revenue and Market Share Analysis of Rong An

    • Table Product and Service Introduction of Rong An

    • Table Company Profile and Development Status of SANOFI

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of SANOFI

    • Figure Sales and Growth Rate Analysis of SANOFI

    • Figure Revenue and Market Share Analysis of SANOFI

    • Table Product and Service Introduction of SANOFI

    • Table Company Profile and Development Status of GSK

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GSK

    • Figure Sales and Growth Rate Analysis of GSK

    • Figure Revenue and Market Share Analysis of GSK

    • Table Product and Service Introduction of GSK

    • Table Company Profile and Development Status of Zhifei

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Zhifei

    • Figure Sales and Growth Rate Analysis of Zhifei

    • Figure Revenue and Market Share Analysis of Zhifei

    • Table Product and Service Introduction of Zhifei

    • Table Company Profile and Development Status of Kangtai

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Kangtai

    • Figure Sales and Growth Rate Analysis of Kangtai

    • Figure Revenue and Market Share Analysis of Kangtai

    • Table Product and Service Introduction of Kangtai

    • Table Company Profile and Development Status of ChengDa Bio

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of ChengDa Bio

    • Figure Sales and Growth Rate Analysis of ChengDa Bio

    • Figure Revenue and Market Share Analysis of ChengDa Bio

    • Table Product and Service Introduction of ChengDa Bio

    • Table Company Profile and Development Status of Hissen

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Hissen

    • Figure Sales and Growth Rate Analysis of Hissen

    • Figure Revenue and Market Share Analysis of Hissen

    • Table Product and Service Introduction of Hissen

    • Table Company Profile and Development Status of Changchun Baike

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Changchun Baike

    • Figure Sales and Growth Rate Analysis of Changchun Baike

    • Figure Revenue and Market Share Analysis of Changchun Baike

    • Table Product and Service Introduction of Changchun Baike

    • Table Company Profile and Development Status of NuoCheng Bio

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of NuoCheng Bio

    • Figure Sales and Growth Rate Analysis of NuoCheng Bio

    • Figure Revenue and Market Share Analysis of NuoCheng Bio

    • Table Product and Service Introduction of NuoCheng Bio

    • Table Company Profile and Development Status of Changsheng Life

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Changsheng Life

    • Figure Sales and Growth Rate Analysis of Changsheng Life

    • Figure Revenue and Market Share Analysis of Changsheng Life

    • Table Product and Service Introduction of Changsheng Life

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US